Search research articles
Contact Us
Filters
Showing results (1-10 of 98) with videos related to
Page
of 10
Sort By:
Advances in Clinical Chemistry
|
March 21, 2024
Advances in familial hypercholesterolemia
Martine Paquette, Alexis Baass
Current Opinion in Lipidology
|
May 1, 2018
Predicting cardiovascular disease in familial hypercholesterolemia
Martine Paquette, Alexis Baass
Clinical Biochemistry
|
February 18, 2019
SLC22A3 is associated with lipoprotein (a) concentration and cardiovascular disease in familial hypercholesterolemia
Martine Paquette, Sophie Bernard, Alexis Baass
Journal of Clinical Lipidology
|
April 11, 2017
The Montreal-FH-SCORE: A new score to predict cardiovascular events in familial hypercholesterolemia
Martine Paquette, Robert Dufour, Alexis Baass
Current Opinion in Lipidology
|
January 23, 2018
Familial hypercholesterolemia: experience from the French-Canadian population
Martine Paquette, Jacques Genest, Alexis Baass
The Canadian Journal of Cardiology
|
September 25, 2017
Scavenger Receptor LOX1 Genotype Predicts Coronary Artery Disease in Patients With Familial Hypercholesterolemia
Martine Paquette, Robert Dufour, Alexis Baass
Journal of Clinical Lipidology
|
May 23, 2018
PHACTR1 genotype predicts coronary artery disease in patients with familial hypercholesterolemia
Martine Paquette, Robert Dufour, Alexis Baass
Clinical Biochemistry
|
April 21, 2025
Lp(a): A Clinical Review
Khalil Anchouche, Alexis Baass, George Thanassoulis
Atherosclerosis
|
September 21, 2021
Hemoglobin concentration, hematocrit and red blood cell count predict major adverse cardiovascular events in patients with familial hypercholesterolemia
Martine Paquette, Sophie Bernard, Alexis Baass
Journal of Clinical Lipidology
|
January 2, 2018
ABO blood group is a cardiovascular risk factor in patients with familial hypercholesterolemia
Martine Paquette, Robert Dufour, Alexis Baass
Page
of 10
Search research articles
Search
Showing results (1-10 of 98) with videos related to
Sort By:
Page
of 10
Advances in Clinical Chemistry
|
March 21, 2024
Advances in familial hypercholesterolemia
Martine Paquette, Alexis Baass
Current Opinion in Lipidology
|
May 1, 2018
Predicting cardiovascular disease in familial hypercholesterolemia
Martine Paquette, Alexis Baass
Clinical Biochemistry
|
February 18, 2019
SLC22A3 is associated with lipoprotein (a) concentration and cardiovascular disease in familial hypercholesterolemia
Martine Paquette, Sophie Bernard, Alexis Baass
Journal of Clinical Lipidology
|
April 11, 2017
The Montreal-FH-SCORE: A new score to predict cardiovascular events in familial hypercholesterolemia
Martine Paquette, Robert Dufour, Alexis Baass
Current Opinion in Lipidology
|
January 23, 2018
Familial hypercholesterolemia: experience from the French-Canadian population
Martine Paquette, Jacques Genest, Alexis Baass
The Canadian Journal of Cardiology
|
September 25, 2017
Scavenger Receptor LOX1 Genotype Predicts Coronary Artery Disease in Patients With Familial Hypercholesterolemia
Martine Paquette, Robert Dufour, Alexis Baass
Journal of Clinical Lipidology
|
May 23, 2018
PHACTR1 genotype predicts coronary artery disease in patients with familial hypercholesterolemia
Martine Paquette, Robert Dufour, Alexis Baass
Clinical Biochemistry
|
April 21, 2025
Lp(a): A Clinical Review
Khalil Anchouche, Alexis Baass, George Thanassoulis
Atherosclerosis
|
September 21, 2021
Hemoglobin concentration, hematocrit and red blood cell count predict major adverse cardiovascular events in patients with familial hypercholesterolemia
Martine Paquette, Sophie Bernard, Alexis Baass
Journal of Clinical Lipidology
|
January 2, 2018
ABO blood group is a cardiovascular risk factor in patients with familial hypercholesterolemia
Martine Paquette, Robert Dufour, Alexis Baass
Page
of 10